Hims & Hers Health Launches 5 Peptide and Longevity Formulations
- 1Hims & Hers Health announced it is offering five compounded peptide and longevity treatments in the U.S.
- 2More than 10,000 people registered on the Hims early access list within 15 days.
- 3The FDA stated it received reports of at least 30 patients experiencing adverse reactions after taking compounded IV glutathione in August.
So what's the key point?
Hims & Hers Health has introduced new wellness medications. While early registrations exceeded 10,000, reports have also been made regarding patients experiencing adverse reactions after taking the medication.
Source CNBC · View original ↗
Nothing hidden: past picks and how they did against the S&P 500.